80 related articles for article (PubMed ID: 26226379)
1. Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents.
Wang S; Fang K; Dong G; Chen S; Liu N; Miao Z; Yao J; Li J; Zhang W; Sheng C
J Med Chem; 2015 Aug; 58(16):6678-96. PubMed ID: 26226379
[TBL] [Abstract][Full Text] [Related]
2. Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents.
Ma Z; Huang Y; Wan K; Zhu F; Sheng C; Chen S; Liu D; Dong G
Bioorg Med Chem Lett; 2021 May; 40():127954. PubMed ID: 33744440
[TBL] [Abstract][Full Text] [Related]
3. Design of Evodiamine-Glucose Conjugates with Improved
Wu Z; Chen S; Chen Z; Dong G; Xu D; Sheng C
J Med Chem; 2024 May; 67(9):7373-7384. PubMed ID: 38646851
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and bioactivity evaluation of the combination of evodiamine and erlotinib linked by indolequinone.
Wei B; Ma J; Guo H; Wang Y; Guo D; Tang Y
Bioorg Med Chem Lett; 2024 Feb; 99():129619. PubMed ID: 38244939
[TBL] [Abstract][Full Text] [Related]
5. Applications of the Pharmacophore Concept in Natural Product inspired Drug Design.
Seidel T; Wieder O; Garon A; Langer T
Mol Inform; 2020 Nov; 39(11):e2000059. PubMed ID: 32578959
[TBL] [Abstract][Full Text] [Related]
6. PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders.
Chen S; Bi K; Liang H; Wu Z; Huang M; Chen X; Dong G; Sheng C
J Adv Res; 2023 Oct; ():. PubMed ID: 37913903
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents.
Hao X; Deng J; Zhang H; Liang Z; Lei F; Wang Y; Yang X; Wang Z
Bioorg Med Chem; 2022 Feb; 55():116595. PubMed ID: 34990980
[TBL] [Abstract][Full Text] [Related]
8. Targeted sampling of natural product space to identify bioactive natural product-like polyketide macrolides.
Wilson DM; Driedger DJ; Liu DY; Keerthisinghe S; Hermann A; Bieniossek C; Linington RG; Britton RA
Nat Commun; 2024 Mar; 15(1):2534. PubMed ID: 38514617
[TBL] [Abstract][Full Text] [Related]
9. Source, Synthesis, and Biological Evaluation of Natural Occurring 2,2'-Bipyridines.
Sharma AN; Verma R
Chem Biodivers; 2023 Dec; 20(12):e202300764. PubMed ID: 37996963
[TBL] [Abstract][Full Text] [Related]
10. Multidirectional desymmetrization of pluripotent building block en route to diastereoselective synthesis of complex nature-inspired scaffolds.
Srinivasulu V; Schilf P; Ibrahim S; Khanfar MA; Sieburth SM; Omar H; Sebastian A; AlQawasmeh RA; O'Connor MJ; Al-Tel TH
Nat Commun; 2018 Nov; 9(1):4989. PubMed ID: 30478283
[TBL] [Abstract][Full Text] [Related]
11. Clustered distribution of natural product leads of drugs in the chemical space as influenced by the privileged target-sites.
Tao L; Zhu F; Qin C; Zhang C; Chen S; Zhang P; Zhang C; Tan C; Gao C; Chen Z; Jiang Y; Chen YZ
Sci Rep; 2015 Mar; 5():9325. PubMed ID: 25790752
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological use of a novel scaffold, anomeric N,N-diarylamino tetrahydropyran: molecular similarity search, chemocentric target profiling, and experimental evidence.
Venkanna A; Kwon OW; Afzal S; Jang C; Cho KH; Yadav DK; Kim K; Park HG; Chun KH; Kim SY; Kim MH
Sci Rep; 2017 Oct; 7(1):12535. PubMed ID: 28970544
[TBL] [Abstract][Full Text] [Related]
13. Two-Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I poison.
Chen YX; Wu S; Shen X; Xu DF; Wang Q; Ji SH; Zhu H; Wu G; Sheng C; Cai YR
Chemistry; 2024 May; ():e202401400. PubMed ID: 38736421
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluations of Electrophilic Steroids Inspired by the Taccalonolides.
Clanton NA; Hastings SD; Foultz GB; Contreras JA; Yee SS; Arman HD; Risinger AL; Frantz DE
ACS Med Chem Lett; 2020 Dec; 11(12):2534-2543. PubMed ID: 33335677
[TBL] [Abstract][Full Text] [Related]
15. Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.
Wang L; Fang K; Cheng J; Li Y; Huang Y; Chen S; Dong G; Wu S; Sheng C
J Med Chem; 2020 Jan; 63(2):696-713. PubMed ID: 31880942
[TBL] [Abstract][Full Text] [Related]
16. Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches.
Sun Q; Xie L; Song J; Li X
J Ethnopharmacol; 2020 Nov; 262():113164. PubMed ID: 32738391
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives.
Hu X; Li D; Chu C; Li X; Wang X; Jia Y; Hua H; Xu F
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380774
[TBL] [Abstract][Full Text] [Related]
18. Scaffold Hopping and Structural Modification of NSC 663284: Discovery of Potent (Non)Halogenated Aminobenzoquinones.
Bayrak N; Sever B; Ciftci H; Otsuka M; Fujita M; TuYuN AF
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255157
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific.
Diesendorf V; Roll V; Geiger N; Fähr S; Obernolte H; Sewald K; Bodem J
Front Cell Infect Microbiol; 2023; 13():1100028. PubMed ID: 37637460
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation.
Liu W; He Y; Guo Z; Wang M; Han X; Jia H; He J; Miao S; Wang S
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2155815. PubMed ID: 36629423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
